Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact
This article was originally published in PharmAsia News
Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.
You may also be interested in...
The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.
Some health-focused Millennium Development Goals are likely to fail to reach a successful benchmark by 2015. Companies are exploring new partnership models for public health achievements.
Health Insurance Firms Likely Big Beneficiaries Of Expanded Public/Private Health Care In Southeast Asia
Health insurance is spreading rapidly across Southeast Asia as public systems expand basic offerings of drugs and care and higher incomes drive demand for cutting edge treatments, according to a study by international consultant Roland Berger.